FDA Clearance Tracker · K200680
Synvitro Hyadase
Last checked: Nov 19, 2026Latest source record: Jul 17, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Jul 17, 2020
Substantially Equivalent
Time to decision
123 days
Received Mar 16, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K200680
- Device name
- Synvitro Hyadase
- Applicant
- Origio A/S, A Coopersurgical Company
- Applicant location
- MåLøV, DK
- Received
- Mar 16, 2020
- Decided
- Jul 17, 2020
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Media, Reproductive (MQL)
- Device class
- Class II
- Regulation
- 21 CFR 884.6180
- Specialty
- Obstetrics & Gynecology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MQL. The earliest in FDA's data is K864524, decided Feb 2, 1987.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K200680
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Origio A/S, A Coopersurgical Company
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.